Remy Sukhija
Net Worth
Last updated:
What is Remy Sukhija net worth?
The estimated net worth of Mr. Remy Sukhija is at least $10,407,273 as of 23 Dec 2022. He owns shares worth $38,500 as insider, has earned $8,224,073 from insider trading and has received compensation worth at least $2,144,700 in Madrigal Pharmaceuticals, Inc..
What is the salary of Remy Sukhija?
Mr. Remy Sukhija salary is $714,900 per year as Senior Vice President & Chief Commercial Officer in Madrigal Pharmaceuticals, Inc..
How old is Remy Sukhija?
Mr. Remy Sukhija is 53 years old, born in 1972.
What stocks does Remy Sukhija currently own?
As insider, Mr. Remy Sukhija owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Madrigal Pharmaceuticals, Inc. (MDGL) | Senior Vice President & Chief Commercial Officer | 100 | $385 | $38,500 |
What does Madrigal Pharmaceuticals, Inc. do?
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.
Remy Sukhija insider trading
Madrigal Pharmaceuticals, Inc.
Mr. Remy Sukhija has made 18 insider trades in 2022, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 60,000 units of MDGL stock on 23 Dec 2022. As of 23 Dec 2022 he still owns at least 100 units of MDGL stock.
Madrigal Pharmaceuticals key executives
Madrigal Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:
- Dr. Paul A. Friedman M.D. (82) Chairman & Chief Executive Officer
- Dr. Rebecca A. Taub M.D. (73) Founder, Chief Medical Officer, Pres of R&D and Director
- Mr. Brian J. Lynch (63) Senior Vice President & Gen. Counsel
- Mr. Remy Sukhija (53) Senior Vice President & Chief Commercial Officer